Level Biotechnology

Level Biotechnology Inventory

The Inventory of Level Biotechnology (3118.TWO) as of Oct 18, 2026 is 115.61 M TWD. In the previous year, Inventory was 98.09 M TWD — a change of 17.85% (higher).

Inventory

115.61 MTWD

YoY

17.85%

Last updated:

Inventory of Level Biotechnology is 2025 115.61 M TWD. Inventory of Level Biotechnology was 2024 98.09 M TWD. It decreases by 17.85% higher compared to the previous year.

The Level Biotechnology Inventory history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Inventory
Date
Inventory
Jan 1, 2018
70.65 M TWD
Jan 1, 2019
76.65 M TWD
Jan 1, 2020
63.56 M TWD
Jan 1, 2021
56.17 M TWD
Jan 1, 2022
73.70 M TWD
Jan 1, 2023
88.85 M TWD
Jan 1, 2024
98.09 M TWD
Jan 1, 2025
115.61 M TWD
The Level Biotechnology Inventory history
YEARInventoryYoY
115.61 MTWD+17.85%
98.09 MTWD+10.40%
88.85 MTWD+20.56%
73.70 MTWD+31.21%
56.17 MTWD-11.63%
63.56 MTWD-17.08%
76.65 MTWD+8.49%
70.65 MTWD-19.64%
87.92 MTWD+36.43%
64.44 MTWD-1.12%
65.17 MTWD-6.13%
69.42 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Level Biotechnology Stock analysis

What does Level Biotechnology do? Level Biotechnology Inc is a company based in Taipei, Taiwan, operating within the Health Care sector. It went public on September 10, 2004, with its ticker symbol 3118.TWO and ISIN TW0003118006. The company provides biotechnological services, focusing on products such as cell culture series, immune protein series, gene nucleic acid and molecular biology series, and instrument series. Additionally, Level Biotechnology offers preclinical testing services, including genetic toxicity testing, general toxicology testing, reproductive toxicology testing, pharmacokinetic testing, and biocompatibility testing. The company's website is https://www.level.com.tw/index_tw.php. Level Biotechnology operates primarily in the domestic market, serving clients within Taiwan. It is headquartered in Taipei, New Taipei, as stated in the provided information. The company's services and products are designed to support research and development in the biotechnology and health care fields. No additional details about founding year, key personnel, acquisitions, or specific financial figures are provided in the given data. The company's activities are centered around delivering specialized biotechnological solutions to its market. Level Biotechnology is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Level Biotechnology stock

Inventory of Level Biotechnology is 115.61 M TWD in 2025.

Inventory of Level Biotechnology changed from 98.09 M TWD to 115.61 M TWD, representing a 17.85% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Inventory Level Biotechnology since 2006 – with annual values, charts, and detailed analysis.

Inventory includes raw materials, work-in-progress, and finished goods. Efficient inventory management is crucial for profitability.

Inventory's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Inventory's Level Biotechnology historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Level Biotechnology

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Level Biotechnology